Business Context and Reporting Period
AFC Gamma, Inc. (the filing identifies the registrant as AFC Gamma, Inc.; the request metadata refers to Advanced Flower Capital Inc.) filed this Form 8-K on June 28, 2021, under Item 8.01, “Other Events.” The filing reports completion of an underwritten public offering of common stock.
Offering and Key Financial Metrics
- Issued 2,750,000 shares of common stock at $20.50 per share.
- Gross proceeds were approximately $56.4 million before underwriting discounts, commissions, and offering expenses, assuming no exercise of the underwriters’ option.
- Granted the underwriters a 30-day option to purchase up to an additional 412,500 shares at the public offering price, less discounts and commissions.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or balance-sheet metrics for a reporting period.
Material Changes Versus Prior Comparable Period
The filing does not present comparative operating or financial results. The material transaction disclosed is the completion of the equity offering and the resulting gross capital raised.
Outlook, Risks, Contingencies, and Unusual Items
- Net proceeds were not stated because underwriting discounts, commissions, and offering expenses had not been deducted in the disclosed amount.
- The final amount of capital raised could increase if the underwriters exercise some or all of their 30-day option; the filing does not state whether the option was exercised as of the filing date.
- The offering was made pursuant to the final prospectus dated June 23, 2021, filed June 24, 2021, under Registration Statement Form S-11, File No. 333-257248.
- No management guidance, operating outlook, contingencies, or specific use of proceeds is provided in the filing text.
Investor Verification Points
- Verify the final net proceeds after underwriting discounts, commissions, and offering expenses.
- Verify whether the underwriters exercised the additional-share option and the resulting total shares outstanding.
- Review the related prospectus for the intended use of proceeds, investment strategy, dilution, and risk factors.
- Confirm the registrant name and ticker: the filing identifies AFC Gamma, Inc., with common stock trading as AFCG on Nasdaq.